Synaptic Plasticity as a Therapeutic Target in the Treatment of Autism-related Single-gene Disorders

E-ISSN： 1873-4286|19|36|6480-6490

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.36, 2013-11, pp. : 6480-6490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prenatal Screening of Single-Gene Disorders from Maternal Blood

By Sekizawa A. Saito H.

American Journal of PharmacoGenomics, Vol. 1, Iss. 2, 2001-01 ,pp. : 111-117

Adis International

Access to resources Recommend Favorite

Targeting Injury-Related Synaptic Plasticity for the Treatment of Chronic Pain

Current Pharmaceutical Design, Vol. 21, Iss. 7, 2015-02 ,pp. : 914-919

Bentham Science Publishers

Access to resources Recommend Favorite

Neuroinflammation: A Therapeutic Target of Cotinine for the Treatment of Psychiatric Disorders?

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1324-1333

Bentham Science Publishers

Access to resources Recommend Favorite

PirB is a novel potential therapeutic target for enhancing axonal regeneration and synaptic plasticity following CNS injury in mammals

By Gou Zhaoyu Mi Yajing Jiang Fengliang Deng Bin Yang Jun Gou Xingchun

Journal of Drug Targeting, Vol. 22, Iss. 5, 2014-06 ,pp. : 365-371

Informa Healthcare

Access to resources Recommend Favorite

The Vasopressin V1b Receptor as a Therapeutic Target in Stress-related Disorders

Current Drug Targets-CNS & Neurological Disorders, Vol. 2, Iss. 3, 2003-06 ,pp. : 191-200

Bentham Science Publishers

Access to resources Recommend Favorite